| Self-report measures of medication adherence behavior: recommendations on optimal use MJ Stirratt, J Dunbar-Jacob, HM Crane, JM Simoni, S Czajkowski, ... Translational behavioral medicine 5 (4), 470-482, 2015 | 858 | 2015 |
| The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness PJ Weiden, M Sajatovic, J Scott, D Carpenter, R Ross, JP Docherty Physicians Postgraduate Press, 2009 | 834 | 2009 |
| Beyond hypofrontality: A quantitative meta‐analysis of functional neuroimaging studies of working memory in schizophrenia DC Glahn, JD Ragland, A Abramoff, J Barrett, AR Laird, CE Bearden, ... Human brain mapping 25 (1), 60-69, 2005 | 775 | 2005 |
| The functional significance of symptomatology and cognitive function in schizophrenia DI Velligan, RK Mahurin, PL Diamond, BC Hazleton, SL Eckert, AL Miller Schizophrenia research 25 (1), 21-31, 1997 | 532 | 1997 |
| Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness DI Velligan, M Sajatovic, A Hatch, P Kramata, JP Docherty Patient preference and adherence, 449-468, 2017 | 396 | 2017 |
| Defining and assessing adherence to oral antipsychotics: a review of the literature DI Velligan, YWF Lam, DC Glahn, JA Barrett, NJ Maples, L Ereshefsky, ... Schizophrenia Bulletin 32 (4), 724-742, 2006 | 388 | 2006 |
| Do specific neurocognitive deficits predict specific domains of community function in schizophrenia? DI Velligan, CC Bow-Thomas, RK Mahurin, AL Miller, LC Halgunseth The Journal of nervous and mental disease 188 (8), 518-524, 2000 | 379 | 2000 |
| Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness PD Harvey, MF Green, RSE Keefe, DI Velligan Journal of Clinical Psychiatry 65 (3), 361-372, 2004 | 343 | 2004 |
| Randomized controlled trial of the use of compensatory strategies to enhance adaptive functioning in outpatients with schizophrenia DI Velligan, CC Bow-Thomas, C Huntzinger, J Ritch, N Ledbetter, ... American Journal of Psychiatry 157 (8), 1317-1328, 2000 | 322 | 2000 |
| Relationships among subjective and objective measures of adherence to oral antipsychotic medications DI Velligan, M Wang, P Diamond, DC Glahn, D Castillo, S Bendle, ... Psychiatric Services 58 (9), 1187-1192, 2007 | 321 | 2007 |
| Performance-based measures of functional skills: usefulness in clinical treatment studies PD Harvey, DI Velligan, AS Bellack Schizophrenia bulletin 33 (5), 1138-1148, 2007 | 318 | 2007 |
| The neurocognitive signature of psychotic bipolar disorder DC Glahn, CE Bearden, M Barguil, J Barrett, A Reichenberg, CL Bowden, ... Biological psychiatry 62 (8), 910-916, 2007 | 305 | 2007 |
| Cognitive rehabilitation for schizophrenia and the putative role of motivation and expectancies DI Velligan, RS Kern, JM Gold Schizophrenia bulletin 32 (3), 474-485, 2006 | 303 | 2006 |
| Does cognitive function improve with quetiapine in comparison to haloperidol? DI Velligan, J Newcomer, J Pultz, J Csernansky, AL Hoff, R Mahurin, ... Schizophrenia research 53 (3), 239-248, 2002 | 245 | 2002 |
| Strategies for addressing adherence problems in patients with serious and persistent mental illness: recommendations from the expert consensus guidelines DI Velligan, PJ Weiden, M Sajatovic, J Scott, D Carpenter, R Ross, ... Journal of Psychiatric Practice® 16 (5), 306-324, 2010 | 240 | 2010 |
| Differential working memory impairment in bipolar disorder and schizophrenia: effects of lifetime history of psychosis DC Glahn, CE Bearden, S Cakir, JA Barrett, P Najt, E Serap Monkul, ... Bipolar disorders 8 (2), 117-123, 2006 | 231 | 2006 |
| Expert Consensus Panel on Adherence Problems in Serious and Persistent Mental Illness. The expert consensus guideline series: adherence problems in patients with serious and … DI Velligan, PJ Weiden, M Sajatovic, J Scott, D Carpenter, R Ross, ... J Clin Psychiatry 70 (Suppl 4), 1-46, 2009 | 229 | 2009 |
| The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia DI Velligan, PM Diamond, J Mintz, N Maples, X Li, J Zeber, L Ereshefsky, ... Schizophrenia bulletin 34 (3), 483-493, 2008 | 228 | 2008 |
| Measurement of psychiatric treatment adherence M Sajatovic, DI Velligan, PJ Weiden, MA Valenstein, G Ogedegbe Journal of psychosomatic research 69 (6), 591-599, 2010 | 223 | 2010 |
| Trail making test errors and executive function in schizophrenia and depression RK Mahurin, DI Velligan, B Hazleton, J Mark Davis, S Eckert, AL Miller The Clinical Neuropsychologist 20 (2), 271-288, 2006 | 216 | 2006 |
